tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

ALBO

Albireo Pharma announces the FDA accepted sNDA, issued PDUFA for Bylvay
The FlyAlbireo Pharma announces the FDA accepted sNDA, issued PDUFA for Bylvay
2y ago
ALBO
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2y ago
ALBO
CALA
Albireo Pharma downgraded to Neutral from Buy at Guggenheim
PremiumThe Fly
Albireo Pharma downgraded to Neutral from Buy at Guggenheim
2y ago
ALBO
Albireo Pharma downgraded to Hold from Buy at Jefferies
PremiumThe Fly
Albireo Pharma downgraded to Hold from Buy at Jefferies
2y ago
ALBO
Albireo Pharma downgraded to Market Perform from Outperform at Cowen
PremiumThe Fly
Albireo Pharma downgraded to Market Perform from Outperform at Cowen
2y ago
ALBO
Albireo Pharma downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe FlyAlbireo Pharma downgraded to Neutral from Buy at H.C. Wainwright
2y ago
ALBO
Albireo Sells Out to Ipsen
Premium
Market News
Albireo Sells Out to Ipsen
2y ago
ALBO
Albireo acquisition ‘good news’ for Mirum Pharmaceuticals, says Piper Sandler
Premium
The Fly
Albireo acquisition ‘good news’ for Mirum Pharmaceuticals, says Piper Sandler
2y ago
ALBO
MIRM
Albireo Pharma downgraded to Neutral from Outperform at Wedbush
PremiumThe Fly
Albireo Pharma downgraded to Neutral from Outperform at Wedbush
2y ago
ALBO
Ipsen to acquire Albireo Pharma for $42.00 per share
PremiumThe Fly
Ipsen to acquire Albireo Pharma for $42.00 per share
2y ago
ALBO
Albireo Pharma submits regulatory filings to FDA, EMA for Bylvay in ALGS
PremiumThe Fly
Albireo Pharma submits regulatory filings to FDA, EMA for Bylvay in ALGS
2y ago
ALBO
Albireo Pharma participates in a conference call with William Blair
PremiumThe Fly
Albireo Pharma participates in a conference call with William Blair
2y ago
ALBO
Albireo Pharma participates in a conference call with William Blair
PremiumThe FlyAlbireo Pharma participates in a conference call with William Blair
2y ago
ALBO
Albireo Pharma participates in a conference call with William Blair
Premium
The Fly
Albireo Pharma participates in a conference call with William Blair
2y ago
ALBO
Albireo Pharma appoints Streck as CMO, Hopkinson to board of directors
Premium
The Fly
Albireo Pharma appoints Streck as CMO, Hopkinson to board of directors
2y ago
ALBO
ALKS
Albireo Pharma reports Q3 EPS ($1.92), consensus ($1.06)
PremiumThe Fly
Albireo Pharma reports Q3 EPS ($1.92), consensus ($1.06)
2y ago
ALBO
Albireo Pharma presented data on Bylvay at the AASLD The Liver Meeting
PremiumThe Fly
Albireo Pharma presented data on Bylvay at the AASLD The Liver Meeting
2y ago
ALBO
Albireo Pharma Delivers Promising Phase 3 results in Alagille Syndrome
PremiumMarket News
Albireo Pharma Delivers Promising Phase 3 results in Alagille Syndrome
2y ago
ALBO
Albireo Pharma (NASDAQ: ALBO) Shoots Up Post Agreement with Sagard
PremiumMarket News
Albireo Pharma (NASDAQ: ALBO) Shoots Up Post Agreement with Sagard
2y ago
ALBO
The Recent Pullback in These 2 Stocks Is a Buying Opportunity, Say Analysts
PremiumStock Analysis & IdeasThe Recent Pullback in These 2 Stocks Is a Buying Opportunity, Say Analysts
3y ago
ALBO
3 “Strong Buy” Pharma Stocks With Fast-Approaching Catalysts
Premium
Stock Analysis & Ideas
3 “Strong Buy” Pharma Stocks With Fast-Approaching Catalysts
4y ago
ALBO
ASMB

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >